SEARCH

SEARCH BY CITATION

References

  • Agarwal, R., Doren, S., Hicks, B., Dunbar, C.E. (1995) Long-term culture of chronic myelogenous leukemia marrow cells on stem cell factor-deficient stroma favors benign progenitors. Blood, 85, 13061312.
  • Apperley, J.F., Jones, L., Hale, G., Goldman, J.M., Galton, D.G. (1986) Bone marrow transplantation for chronic myeloid leukemia: T cell depletion with Campath-1 reduces the incidence of acute graft-versus-host disease but may increase the risk of leukemia relapse. Bone Marrow Transplantation, 1, 5366.
  • Bacigalupo, A., Van Lint, M.T., Valbonesi, M., Lercari, G., Carlier, P., Lamparelli, T., Gualandi, F., Occhini, D., Bregante, S., Veleriani, A., Piaggo, G., Pitto, A., Benvenuto, F., Figari, O., De Stefano, G., Camio, A., Sessarego, M. (1996) Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood stem cells in adults with advanced leukemia. Blood, 88, 353357.
  • Bacigalupo, A., Zikos, P., Van Lint, M.T., Valbonesi, M., Lamparelli, T., Gualandi, F., Occhini, D., Mordini, N., Bregante, S., Berrisso, G., Vitale, V., Sessarego, M., Marmont, A.M. (1998) Allogeneic bone marrow or peripheral blood cell transplant in adults with hematopoietic malignancies: a single-center experience. Experimental Hematology, 26, 409414.
  • Bahceci, E., Read, E.J., Leitman, S., Childs, R., Dunbar, C., Young, N.S., Barrett, A.J. (2000) CD34+ cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies. British Journal of Haematology, 108, 408414.
  • Barrett, A.J., Mavroudis, D., Tisdale, J., Molldrem, J., Clave, E., Dunbar, C., Cotter-Fox, M., Phang, S., Carter, C., Okunnieff, P., Young, N.S., Read, E.J. (1998) T cell-depleted bone marrow transplantation and delayed add-back to control acute GVHD and conserve a graft-versus-leukemia effect. Bone Marrow Transplantation, 21, 543551.
  • Bensinger, W., Weaver, C., Appelbaum, F., Rowley, S., Demirer, T., Sanders, J., Storb, R., Buckner, C.D. (1995) Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood, 85, 16551658.
  • Bensinger, W.I., Clift, R., Martin, P., Appelbaum, F.R., Demirer, T., Gooleg, T., Lilleby, K., Rowley, S., Sanders, J., Storb, R., Buckner, C.D. (1996) Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood, 88, 27942800.
  • Brown, R.A., Adkins, D., Khoury, R., Vig, R., Goodnough, L.T., Shenoy, S., DiPersio, J.F. (1999) Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: Graft-versus-host disease and transplant related mortality. Journal of Clinical Oncology, 17, 806812.
  • Butturini, A. & Gale, R.P. (1988) T-cell depletion in bone marrow transplantation for leukemia: current results and future directions. Bone Marrow Transplantation, 3, 185192.
  • Couriel, D., Canosa, J., Engler, H., Collins, A., Dunber, C., Barrett, A.J. (1996) Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies. Bone Marrow Transplantation, 18, 347353.
  • Drobyski, W., Hessner, M.J., Klein, J.P., Kabler-Babbitt, C., Vesole, D.H., Margolis, D.A., Keever-Taylor, C.A. (1999) T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation. Blood, 94, 434441.
  • Fowler, D.H., Breglio, J., Nagel, G., Eckhaus, M.A., Gress, R.E. (1996) Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease. Journal of Immunology, 157, 48114821.
  • Goldman, J.M. (1995) Peripheral blood stem cells for allografting. Blood, 85, 14131415(review).
  • Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.J., Rimm, A.A., Ringden, O., Rozman, O., Speck, B., Truitt, R.L., Zwaan, F.E., Bortin, M.M. (1990) Graft-versus-Leukemia reactions after bone marrow transplantation. Blood, 75, 555562.
  • Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of American Statistical Association, 53, 457481.
  • Lane, T.A., Law, P., Maruyama, M., Young, D., Burgess, J., Mullen, M., Terstappen, L.W., Hardwick, A., Moubayed, M., Oldham, F., Corringham, R., Ho, A.D. (1995) Harvesting and enrichment of allogeneic peripheral blood progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood, 85, 275282.
  • Link, H., Arseniev, L., Ljungman, P., Alessandrino, E.P., Amadori, S., Bandini, G., Beguin, Y., Brinch, L., Brunet, S., Chopra, R., Cordonnier, C., De Wette, T., FauSeries, A., Ferrant, A., Garcia-Conde, J., Juliusson, G., Kubel, M., Manna, A.T., Martinez-Rubio, A.M., Mundhenk, P., Ordemann, R., Ortega, J.J., Potter, M., Prentice, H.G., Raimondi, R., Remez, K., Reusser, P., Rovira, M., Russell, J., Selleslag, D., Uderzo, C., Zaucha, J.M. (1997) Cytomegalovirus infections after allogeneic peripheral blood progenitor cell transplantation (PBSCT) – a survey of the infectious disease working party of EBMT [Abstract]. Blood, 90 (Suppl. 1), 544a.
  • Majolino, I., Saglio, G., Scime, R., Serra, A., Cavallaro, A.M., Fiandaca, T., Vasta, S., Pampinella, M., Catania, P., Indovina, A., Marceno, R., Santoro, A. (1996) High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. Bone Marrow Transplantation, 17, 555560.
  • Marmont, A.M., Horowitz, M.M., Gale, R.P., Sobocinski, K., Ash, R.C., Van Bekkum, D.W., Champlin, R.E., Dicke, K.A., Goldman, J.M., Good, R.A., Herzig, R.H., Hong, R., Masaoka, T., Rimm, A.A., Ringden, O., Speck, B., Weiner, R.S., Bortin, M.M. (1991) T-cell depletion of HLA-identical transplants in leukemia. Blood, 78, 21202130.
  • Mavroudis, D., Read, E., Cottler-Fox, M., Couriel, D., Molldrem, J., Carter, C., Yu, M., Dunbar, C., Barrett, J. (1996) CD34+ cell dose predicts survival, post-transplant morbidity and rate of haematological recovery after allogeneic marrow transplants for haematologic malignancies. Blood, 88, 32233229.
  • Mavroudis, D.A., Jiang, Y.Z., Hensel, N., Lewalle, P., Couriel, D., Kreitman, R.J., Pastan, I., Barrett, A.J. (1998) Specific depletion of alloreactive T cells in HLA-identical siblings: a method for separating graft-versus-host and graft-versus-leukaemia reactions. British Journal of Haematology, 101, 565570.DOI: 10.1046/j.1365-2141.1998.00748.x
  • Pan, L., Delmonte, Jr, J., Jalonen, C.K., Ferrara, J.L. (1995) Pretreatment of donor mice with granulocyte colony stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood, 86, 44224429.
  • Pavletic, Z.S., Bishop, M., Tarantolo, S.R., Martin-Algarra, S., Bierman, P.J., Vose, J.M., Reed, E.C., Gross, T.G., Kollath, J., Nasrati, K., Jackson, J.D., Armitage, J.O., Kessinger, A. (1997) Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies. Journal of Clinical Oncology, 15, 16081616.
  • Peto, R. & Peto, J. (1972) Asymptotically efficient rank invariant procedures. Journal of the Royal Statistical Society, 135, 185194.
  • Prentice, H.G., Gluckman, E., Powles, R., Ljungman, P., Milpied, N., Fernandez Ranada, J.M., Mandelli, F., Kho, P., Kennedy, L., Bell, A.R. for the European Acyclovir for CMV Prophylaxis Study Group (1994) Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. Lancet, 343, 749753.
  • Przepiorka, D., Anderlini, P., Ippoliti, C., Khouri, I., Fietz, T., Thall, P., Mehra, R., Giralt, S., Gajewski, J., Deisseroth, A.B., Cleary, K., Champlin, R., Van Besien, K., Andersson, B., Korbling, M. (1997) Allogeneic blood stem cell transplantation in advanced hematologic cancers. Bone Marrow Transplantation, 19, 455460.
  • Quinones, R.R., Lunney, J., Gress, R.E. (1988) An anti-human-T-cell monoclonal antibody with specificity for a novel determinant. Transplantation, 46, 143150.
  • Russell, J.A., Desai, S., Herbut, B., Brown, C., Ludier, J., Reuther, J.D., Stewart, D., Chaudhry, A., Booth, K., Jorgenson, K., Coppes, M.J., Turner, A.R., Larratt, L., Poon, M.C., Klassen, J. (1997) Partially mismatched blood cell transplants for poor-risk hematologic malignancy. Bone Marrow Transplantation, 19, 861866.
  • Russell, J.A., Larratt, L., Brown, C., Turner, A.R., Chaudhry, A., Booth, K., Woodman, R.C., Wolff, J., Valentine, K., Stewart, D., Reuther, J.D., Reuther, B.A., Klassen, J., Jones, A.R., Gyonyor, E., Egeler, M., Dunsmore, J., Desai, S., Coppes, M.J., Bowen, T., Anderson, R., Poon, M.C. (1999) Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: influence of stem cell source on outcome. Bone Marrow Transplantation, 24, 11771183.
  • Schmitz, N., Dreger, P., Suttorp, M., Rohwedder, E.B., Haferlach, T., Lottler, H., Hunter, A., Russell, N.H. (1995) Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by Filgastrim (G-CSF). Blood, 85, 16661674.
  • Slavin, S., Naparstek, E., Nagler, A., Ackerstein, A., Samuel, S., Kapelushnik, J., Brautbar, C., Or, R. (1996) Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood, 87, 21952204.
  • Storek, J., Gooley, T., Siadak, M., Bensinger, W.I., Maloney, D.G., Chauncey, T.R., Flower, S.M., Sullivan, K.M., Witherspoon, R.P., Rowley, S.D., Hansen, J.A., Storb, R., Appelbaum, F.R. (1997) Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood, 90, 47054709.
  • Thomas, E.D., Storb, R., Clift, R.A., Feter, A., Johnson, L., Neiman, P.E., Lerner, K.G., Glucksberg, H., Buckner, C.D. (1975) Bone marrow transplantation. New England Journal of Medicine, 1975, 832843.
  • Urbano-Ispizua, A., Garcia-Conde, S., Brunet, S., Hernandez, F., Sanz, G., Alegre, A., Petit, J., Bargay, J., Vivancos, P., Solano, C., Ojeda, E., Domingo, A., Rozman, C. (1996) High incidence of chronic GVHD after allogeneic peripheral blood progenitor cell transplantation from matched related donors [Abstract]. Blood, 88, 617a.
  • Urbano-Ispizua, A., Solano, C., Brunet, S., De La Rubia, J., Odriozola, J., Zuazu, J., Fignera, A., Caballero, D., Martinez, C., Garcia, J., Sanz, G., Torrabadella, M., Alegre, A., Perez-Oteiza, J., Jurado, M., Oyonarte, S., Sierra, J., Garcia-Conde, J., Rozman, C. (1998) Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoabsorption or immunomagnetic techniques. Spanish Group of Allo-PBT. Bone Marrow Transplantation, 22, 519525.
  • Urbano-Ispizua, A., Rozman, C., Pimental, P., Solano, C., De La Rubia, J., Brunet, S., Perez-Oteiza, J., Ferra, C., Zuazu, J., Caballero, D., Carvalhais, A., Diez, J.L., Espigado, I., Martinez, C., Campilho, F., Sanz, M.A., Sierra, J., Garcia-Conde, J., Montserrat, E. (2001) The number of donor CD3+ cells is the most important factor for graft failure after allogeneic transplantation of CD34+ selected cells from peripheral blood from HLA-identical siblings. Spanish Group of Allo-PBT. Blood, 97, 383387.
  • Walter, E.A., Greenberg, P.D., Gilbert, M.J., Finch, R.J., Watanabe, K.S., Thomas, E.D., Riddell, S.R. (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. New England of Journal of Medicine, 333, 10381044.